China, AstraZeneca

AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.
AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud
BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” to AstraZeneca, but contends that the share selloff is “overdone” and likely a knee-jerk reaction by investors.
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the company said.
AstraZeneca: China's investigation into exec separate from medical insurance probe
AstraZeneca said on Wednesday that to its knowledge an ongoing investigation by Chinese authorities into the company's top executive in the country, Leon Wang, is separate from a large health insurance fraud case also involving the company.
AstraZeneca extends losses as Chinese probe widens
AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.
AstraZeneca falls on reports of Chinese probe
Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of senior executives in the company's China subsidiary have been implicated in an insurance fraud case.
Asia One1h
Daily roundup: AstraZeneca to open new $2b facility in Tuas by 2029, promises 800 jobs — and other top stories today
Stay in the know with a recap of our top stories today. 1. AstraZeneca to open new $2b facility in Tuas by 2029, promises 800 ...
AstraZeneca says experimental obesity pill safe in early-stage trial
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday it ...
AstraZeneca in talks with authorities as China boss is detained
AstraZeneca is holding crisis talks with the Chinese authorities after the arrest of its boss in the country. The ...
Zacks.com on MSN1d
Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings
Key Takeaways Zacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture ...
Hong Kong Free Press13h
China head of pharmaceutical giant AstraZeneca detained after reports of probe into illegal drug imports
Pharmaceutical giant AstraZeneca has confirmed that Leon Wang, the head of its China operations, had been detained.
China Has Detained a Senior AstraZeneca Executive
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...
Why Is AstraZeneca Stock Sinking On Tuesday?
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...